A generic pharmaceutical manufacturer, Glenmark Pharmaceuticals Inc. USA (Glenmark), located in Mahwah, New Jersey, has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug. Read More
Home » Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Related Posts
Former Maury County, Tennessee, Corrections Officer Sentenced for
A former corrections officer of the Maury County, Tennessee, Jail was sentenced yesterday in federal court in Nashville, Tennessee, to 60 months in prison and… BronFormer Maury County, Tennessee, Corrections Officer Sentenced for
Sixteen Cardiology Practices to Pay a Total of $17.7M to Resolve False
Sixteen separate cardiology practices and associated physicians, located across 12 states, have agreed to pay amounts totaling $17,761,564 to resolve allegations that they each violated… BronSixteen Cardiology Practices to Pay a Total of $17.7M to Resolve False
United States Joins Lawsuit Against Former Executives of Kabbage Inc.
The United States has intervened and filed a complaint against Robert Frohwein, Kathryn Petralia and Spencer Robinson, three former executives of Kabbage Inc., a now-bankrupt… BronUnited States Joins Lawsuit Against Former Executives of Kabbage Inc.